Compare PK & PGNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PK | PGNY |
|---|---|---|
| Founded | 1946 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Misc Health and Biotechnology Services |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.1B |
| IPO Year | N/A | 2019 |
| Metric | PK | PGNY |
|---|---|---|
| Price | $11.71 | $21.57 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 11 | 10 |
| Target Price | $11.55 | ★ $27.90 |
| AVG Volume (30 Days) | ★ 3.9M | 1.4M |
| Earning Date | 02-19-2026 | 02-26-2026 |
| Dividend Yield | ★ 8.50% | N/A |
| EPS Growth | N/A | ★ 2.96 |
| EPS | N/A | ★ 0.62 |
| Revenue | ★ $2,541,000,000.00 | $1,268,689,000.00 |
| Revenue This Year | $0.08 | $11.63 |
| Revenue Next Year | $0.08 | $9.52 |
| P/E Ratio | ★ N/A | $34.82 |
| Revenue Growth | N/A | ★ 11.41 |
| 52 Week Low | $8.27 | $17.98 |
| 52 Week High | $13.23 | $28.75 |
| Indicator | PK | PGNY |
|---|---|---|
| Relative Strength Index (RSI) | 60.62 | 30.53 |
| Support Level | $11.04 | $21.25 |
| Resistance Level | $11.59 | $23.59 |
| Average True Range (ATR) | 0.34 | 0.88 |
| MACD | 0.06 | -0.31 |
| Stochastic Oscillator | 89.34 | 16.70 |
Park Hotels & Resorts owns upper-upscale and luxury hotels, with 22,395 rooms across 36 hotels in the United States. Park also has interests through joint ventures in another 2,271 rooms in three US hotels. Park was spun out of Hilton Worldwide Holdings at the start of 2017, so most of its hotels are still under Hilton brands. The company has sold all its international hotels and many of its lower-quality US hotels to focus on high-quality assets in domestic gateway markets.
Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.